spironolactone has been researched along with Remission, Spontaneous in 6 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.
Excerpt | Relevance | Reference |
---|---|---|
"N(G)-nitro-L-arginine-methyl ester (L-NAME)-induced hypertension is associated with protein remodeling of the left ventricle." | 7.74 | Spontaneous, L-arginine-induced and spironolactone-induced regression of protein remodeling of the left ventricle in L-NAME-induced hypertension. ( Adamcová, M; Krajcírovicová, K; Matúsková, J; Paulis, L; Pechánová, O; Pelouch, V; Potácová, A; Simko, F, 2007) |
"Primary aldosteronism (PA) is mainly caused by aldosterone-producing adenoma and idiopathic bilateral adrenal hyperplasia (IHA)." | 5.38 | Spontaneous remission of idiopathic aldosteronism after long-term treatment with spironolactone: results from the German Conn's Registry. ( Beuschlein, F; Bidlingmaier, M; Degenhart, C; Fischer, E; Jung, P; Reincke, M, 2012) |
"N(G)-nitro-L-arginine-methyl ester (L-NAME)-induced hypertension is associated with protein remodeling of the left ventricle." | 3.74 | Spontaneous, L-arginine-induced and spironolactone-induced regression of protein remodeling of the left ventricle in L-NAME-induced hypertension. ( Adamcová, M; Krajcírovicová, K; Matúsková, J; Paulis, L; Pechánová, O; Pelouch, V; Potácová, A; Simko, F, 2007) |
"Primary aldosteronism (PA) is mainly caused by aldosterone-producing adenoma and idiopathic bilateral adrenal hyperplasia (IHA)." | 1.38 | Spontaneous remission of idiopathic aldosteronism after long-term treatment with spironolactone: results from the German Conn's Registry. ( Beuschlein, F; Bidlingmaier, M; Degenhart, C; Fischer, E; Jung, P; Reincke, M, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Mai, X | 3 |
Kometani, M | 3 |
Yoneda, T | 3 |
Fischer, E | 1 |
Beuschlein, F | 1 |
Degenhart, C | 1 |
Jung, P | 1 |
Bidlingmaier, M | 1 |
Reincke, M | 1 |
Simko, F | 1 |
Potácová, A | 1 |
Pelouch, V | 1 |
Paulis, L | 1 |
Matúsková, J | 1 |
Krajcírovicová, K | 1 |
Pechánová, O | 1 |
Adamcová, M | 1 |
Kokenge, F | 1 |
Liedtke, R | 1 |
Zepf, S | 1 |
Olbing, H | 1 |
Greifer, I | 1 |
Bennett, BP | 1 |
Bernstein, J | 1 |
Spitzer, A | 1 |
Gabriele, C | 1 |
Gabriele, S | 1 |
Bandiermonte, Z | 1 |
1 review available for spironolactone and Remission, Spontaneous
Article | Year |
---|---|
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; | 2022 |
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; | 2022 |
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; | 2022 |
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; | 2022 |
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; | 2022 |
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; | 2022 |
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; | 2022 |
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; | 2022 |
Spontaneous Remission of Primary Aldosteronism with Mineralocorticoid Receptor Antagonist Therapy: A Review.
Topics: Aldosterone; Humans; Hyperaldosteronism; Mineralocorticoid Receptor Antagonists; Mineralocorticoids; | 2022 |
5 other studies available for spironolactone and Remission, Spontaneous
Article | Year |
---|---|
Spontaneous remission of idiopathic aldosteronism after long-term treatment with spironolactone: results from the German Conn's Registry.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Hyperaldosteronism; Male; Middle Aged; Mineralocorti | 2012 |
Spontaneous, L-arginine-induced and spironolactone-induced regression of protein remodeling of the left ventricle in L-NAME-induced hypertension.
Topics: Animals; Arginine; Blood Pressure; Collagen; Hypertension; Hypertrophy, Left Ventricular; Male; Mine | 2007 |
[A contribution on diagnostic and therapy of myxoedema coma (author's transl)].
Topics: Aged; Coma; Female; Humans; Hyperaldosteronism; Myxedema; Remission, Spontaneous; Spironolactone; Tr | 1975 |
Idiopathic membranous nephropathy in children.
Topics: Adolescent; Age Factors; Aminohippuric Acids; Basement Membrane; Biopsy; Child; Child, Preschool; Cr | 1973 |
[Prednisone and immunosuppressive agents in the therapy of nephrotic syndrome in infancy].
Topics: Child; Child, Preschool; Drug Synergism; Female; Humans; Immunosuppressive Agents; Infant; Male; Nep | 1971 |